Increased preoperative thrombin generation and low protein S level associated with unfavorable postoperative hemodynamics after coronary artery bypass grafting

Abstract

In a previous study, preoperative levels of activated protein C (APC) were associated with unfavorable postoperative hemodynamics after coronary artery bypass grafting (CABG). Protein C is activated by thrombin. Protein S, the cofactor of activated protein C, has activated protein C-independent anticoagulant activity and cytoprotective effects. Therefore, the objective of this study was to test whether preoperative, baseline levels of either thrombin or protein S were associated with hemodynamic performance or markers of myocardial damage after CABG. One hundred patients undergoing elective on-pump CABG were prospectively studied. Prothrombin fragment F1+2 (a marker of thrombin generation) and free protein S were measured preoperatively and cardiac index, systemic vascular resistance index (SVRI), and pulmonary vascular resistance index (PVRI) were measured serially thereafter at fixed time points. Cardiac biomarkers CK-MBm and TnT were measured postoperatively. There was an inverse correlation between preoperative F1+2 and free protein S levels (r= —0.30, p=0.003). High preoperative F1+2 and low preoperative protein S levels were associated with a less favorable hemodynamic profile postoperatively. Patients with F1+2 in the highest decile (≥0.85 nmol/l) and patients with preoperative protein S in the lowest decile (≤63%) had lower CI values, and higher pulmonary and systemic vascular resistance index values postoperatively than comparison patients. Preoperative F1+2 or protein S did not correlate with postoperative cardiac biomarker levels. Baseline activation of coagulation and the balance between pro-coagulant and anti-coagulant factors preoperatively might have implications for postoperative hemodynamic recovery after CABG.

Keywords

blood coagulation CABG surgery cardiopulmonary bypass

Get full access to this article

View all access options for this article.

References

Griffin JH Blood coagulation. The thrombin paradox. Nature 1995: 378: 337-338.

Mosnier LO , Zlokovic BV , Griffin JH The cytoprotective protein C pathway. Blood 2007: 109: 3161-3172.

Raivio P. , Lassila R. , Petäjä J. Thrombin in myocardial ischemia-reperfusion during cardiac surgery. Ann Thorac Surg 2009: 88: 318-325.

Raivio P. , Kuitunen A. , Suojaranta-Ylinen R. , et al. Thrombin generation during reperfusion after coronary artery bypass surgery associates with postoperative myocardial damage. J Thromb Haemost 2006: 4: 1523-1529.

Dixon B. , Santamaria J. , Campbell D. Coagulation activation and organ dysfunction following cardiac surgery. Chest 2005: 128: 229-236.

Raivio P. , Fernandez JA , Kuitunen A. , et al. Activation of protein C and hemodynamic recovery after coronary artery bypass surgery. J Thorac Cardiovasc Surg 2007: 133: 44-51.

Hackeng TM , Sere KM , Tans G. , et al. Protein S stimulates inhibition of the tissue factor pathway by tissue factor pathway inhibitor. Proc Natl Acad Sci U S A 2006: 103: 3106-3111.

Anderson HA , Maylock CA , Williams JA , et al. Serum-derived protein S binds to phosphatidylserine and stimulates the phagocytosis of apoptotic cells. Nat Immunol 2003: 4: 87-91.

Liu D. , Guo H. , Griffin JH , et al. Protein S confers neuronal protection during ischemic/hypoxic injury in mice. Circulation 2003: 107: 1791-1796.

10.

Januzzi JL , Lewandrowski K. , MacGillivray TE , et al. A comparison of cardiac troponin T and creatine kinase-MB for patient evaluation after cardiac surgery. J Am Coll Cardiol 2002: 39: 1518-1523.

11.

Kathiresan S. , Servoss SJ , Newell JB , et al. Cardiac troponin T elevation after coronary artery bypass grafting is associated with increased one-year mortality . Am J Cardiol 2004: 94: 879-881.

12.

Levi M. , Choi G. , Schoots I. , et al. Beyond sepsis: activated protein C and ischemia-reperfusion injury. Crit Care Med 2004: 32(5Suppl): S309-312.

13.

Rezende SM , Simmonds RE , Lane DA Coagulation, inflammation, and apoptosis: different roles for protein S and the protein S-C4b binding protein complex. Blood 2004: 103: 1192-1201.

14.

Mosnier LO , Meijers JC , Bouma BN The role of protein S in the activation of thrombin activatable fibrinolysis inhibitor (TAFI) and regulation of fibrinolysis. Thromb Haemost 2001: 86: 1040-1046.

15.

Dahlbäck B. , Villoutreix BO Regulation of blood coagulation by the protein C anticoagulant pathway: novel insights into structure-function relationships and molecular recognition. Arterioscler Thromb Vasc Biol 2005: 25: 1311-1320.

16.

Bellosta P. , Zhang Q. , Goff SP , et al. Signaling through the ARK tyrosine kinase receptor protects from apoptosis in the absence of growth stimulation . Oncogene 1997: 15: 2387-2397.

17.

Nakano T. , Kawamoto K. , Higashino K. , et al. Prevention of growth arrest-induced cell death of vascular smooth muscle cells by a product of growth arrest-specific gene, gas6. FEBS Lett 1996: 387: 78-80.

18.

Gasic GP , Arenas CP , Gasic TB , et al. Coagulation factors X, Xa, and protein S as potent mitogens of cultured aortic smooth muscle cells. Proc Natl Acad Sci U S A 1992: 89: 2317-2320.

19.

Benzakour O. , Formstone C. , Rahman S. , et al. Evidence for a protein S receptor(s) on human vascular smooth muscle cells. Analysis of the binding characteristics and mitogenic properties of protein S on human vascular smooth muscle cells . Biochem J 1995: 308: 481-485.

20.

Benzakour O. , Kanthou C. The anticoagulant factor, protein S, is produced by cultured human vascular smooth muscle cells and its expression is up-regulated by thrombin. Blood 2000: 95: 2008-2014.